New Coronavirus COVID-19 (SARS-CoV-2)

Шамшева, О. В.

doi:10.22627/2072-8107-2020-19-1-5-6

Cited by 37 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Sin embargo, es importante recalcar que la tasa de mortalidad del COVID-19 en toda la población es solamente del 2%. [8][9][10][11] Es una enfermedad infecciosa de alta transmisibilidad, por contacto directo a través de gotículas en aerosol expulsadas por la boca y la nariz hacia el aire por medio de la tos, el estornudo o al hablar. Los síntomas suelen aparecer entre el segundo y catorceavo día posterior a la infección, sin embargo, el paciente puede transmitir la enfermedad aún durante el período asintomático.…”

Section: Introductionunclassified

Aspectos clínicos de importancia en pacientes sospechosos o confirmados con COVID-19 hospitalizados. Centro Médico Docente la Trinidad: Revisión de casos

Miskiewicz¹,

Ferrari²,

Delgado³

et al. 2023

Rev Cien CMDLT

View full text Add to dashboard Cite

El objetivo del presente trabajo fue describir las características clínicas de los pacientes con sospecha o confirmación de COVID-19 hospitalizados en el Centro Médico Docente La Trinidad (CMDT) entre agosto y septiembre del 2020. Metodología: estudio de tipo observacional, serie de casos. La muestra de 144 pacientes se obtuvo por muestreo aleatorio. Resultados: la mayoría fueron pacientes entre 60-79 años (42,1%) a predominio masculino (69%). Se obtuvo confirmación diagnóstica de COVID-19, sólo en el 13,2% de los casos. El 64% presentaban comorbilidades, predominantemente cardiovasculares y metabólicas. Los principales motivos de consulta fueron disnea (53,5%), fiebre (15,9%) y tos (12,5%); 62,5% recibió tratamiento ambulatorio previa hospitalización. Durante la hospitalización 89,5% recibió esteroides, 91,6% recibió anticoagulantes, y 36,8% tratamiento antiviral. El 11,1% de los pacientes ingresó a la Unidad de Terapia Intensiva (UTI), de los cuales, 56% requirió ventilación mecánica. La mortalidad encontrada, fue de 10.4%, inferior a la reportada en la literatura, y principalmente en UTI (6,3%). Se evidenció elevación del dímero D entre los 7-9 días de enfermedad mientras que los reactantes de fase aguda aumentaron progresivamente el curso de la enfermedad, presentando un pico entre los 13-15 días posterior al inicio de los síntomas. Conclusión: la disnea resultó ser el principal motivo de consulta en este estudio. Considerar los parámetros bioquímicos relacionados a hepatopatía y posibles implicaciones de hipoalbuminemia en el edema intersticial. El seguimiento de reactantes de fase aguda puede predecir la aparición de tormenta de citoquinas entre los días 13-15 de enfermedad.

show abstract

Section: Introductionunclassified

Aspectos clínicos de importancia en pacientes sospechosos o confirmados con COVID-19 hospitalizados. Centro Médico Docente la Trinidad: Revisión de casos

Miskiewicz¹,

Ferrari²,

Delgado³

et al. 2023

Rev Cien CMDLT

View full text Add to dashboard Cite

show abstract

“…In 2012, a new reassortant coronavirus, called MERS, causing Middle East Respiratory Syndrome was recorded. SARS-CoV and MERS were characterized by high mortality rates, however, the latter was quickly localized [1,2].…”

Section: Introductionmentioning

confidence: 99%

Features of the course of Covid-19 infection in children

Nakhusheva,

Yurchenko,

Sviridova

et al. 2023

View full text Add to dashboard Cite

The COVID-19 infection has become an unexpected challenge for global health in recent years. The SARS-CoV-2 virus, which causes severe illness in adults, was most often asymptomatic in the pediatric population. However, since the appearance of the new virus, the estimated share of infected children has risen from less than 2% to 8.5% of all infected patients. Taking into account the fact that asymptomatic and oligosymptomatic pediatric patients most often do not complain, it can be assumed that the exact occurrence rate of the SARS-CoV-2 virus among children is higher than officially published data. Similarly to adults, the presence of comorbidities in children was associated with severe forms of the coronavirus infection and the need for intensive care. The clinical pattern of COVID-19 in children is not fundamentally different from that in adult patients, but however, gastrointestinal symptoms are found much more often. In addition, complications characteristic of the pediatric population are observed. The aim hereof was to analyze the features of the manifestation of the COVID-19 infection in pediatric patients.

show abstract

“…Coronaviruses are the most striking example of a virus that was twice able to overcome the interspecies barrier between wild animals and humans during SARS and MERS outbreaks. SARS-CoV-2 is suspected to possibly overcome this barrier for the third time [17]. SARS-CoV-2 coronavirus is probably a recombinant virus between the bat coronavirus (RaTG13-2013, identity is 96 %) and another coronavirus of unknown origin.…”

mentioning

confidence: 99%

“…SARS-CoV-2 coronavirus is probably a recombinant virus between the bat coronavirus (RaTG13-2013, identity is 96 %) and another coronavirus of unknown origin. The genetic sequence of SARS-CoV-2 is similar to that of SARS-CoV at least by 79 % [17,18]. To scientists' opinion, it is vital to examine an intermediate host since it.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Epidemiologic aspects in prevention of the new coronavirus infection (COVID-19) (Literature review)

Butaev¹,

Tsirikhova²,

Kabaloeva³

et al. 2022

Health Risk Analysis

View full text Add to dashboard Cite

At the end of 2019 the mankind had to face a new coronavirus infection with higher virulence which resulted in its rapid spread all over the world and in an ultimate pandemic. Initially a new virus which causes COVID-19 was called 2019-nCoV but it soon acquired its well-known name, SARS-CoV-2. We can positively state that this new coronavirus infection will remain in the history of world public healthcare as a disease that caused a collapse in rendering medical aid. Undoubtedly, this new coro-navirus infection has changed customary lifestyle of the overall world population. This review can be considered problematic in its essence and focuses on examining contemporary trends in the official epidemiologic situation in the world regarding the new coronavirus infection (SARS-CoV-2). Having analyzed several foreign and domestic documents, the authors revealed a necessity to enhance levels and quality of COVID-19 epidemiologic diagnostics. There is a suggestion being considered at the moment on including additional clinical and diagnostic activities aimed at preventing further spread of the new coronavirus infection. We should note that data on COVID-19-related mortality and morbidity are renewed every day and every hour. Given that, it seems rather difficult to keep in line with the latest trends in COVID-19 prevention and epidemiologic diagnostics. However, the authors made an attempt to possibly collect all the latest data on epidemiological peculiarities related to the clinical course of the new coronavirus infection. The authors have a hope that this review will be useful for epidemiologists when they detect new cases of the disease as well as for lecturers at medical higher educational establishments when they train students and resident physicians.

show abstract

New Coronavirus COVID-19 (SARS-CoV-2)

Cited by 37 publications

References 0 publications

Aspectos clínicos de importancia en pacientes sospechosos o confirmados con COVID-19 hospitalizados. Centro Médico Docente la Trinidad: Revisión de casos

Aspectos clínicos de importancia en pacientes sospechosos o confirmados con COVID-19 hospitalizados. Centro Médico Docente la Trinidad: Revisión de casos

Features of the course of Covid-19 infection in children

Epidemiologic aspects in prevention of the new coronavirus infection (COVID-19) (Literature review)

Contact Info

Product

Resources

About